🔎 Trials Near Me

መነሻ › ኒውሮብላስቶማ › ማሳቹሴትስ

በማሳቹሴትስ ለኒውሮብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለኒውሮብላስቶማ የሚደረጉ 13 ጥናቶች በማሳቹሴትስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በማሳቹሴትስ ውስጥ ያሉ ከተሞች

Official study text (English)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06172296

MCT for the Harvard/UCSF ROBIN Center

  • Brigham and Women's Hospital, Boston
ተሳታዮችን በመፈለግ ላይ
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06000787

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Dana-Farber Cancer Institute ( Site 1013), Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
6 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06395103

B7-H3.CD28Z.CART in Solid Tumors

  • Dana Farber Cancer Institite, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
9 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07358260

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

  • Dana Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ2 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

  • Boston Children's Hospital, Dana-Farber Cancer Institute., Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 31 · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2026 · NCT06450041

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT07027748

Neuroblastoma Biology Study

  • Children's Hospital Boston, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
31 Days – 99 Years · ሁሉም ጾታዎች · የተሻሻለው በ23 ማርች 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይ
እስከ እድሜ 17 · ሁሉም ጾታዎች · የተሻሻለው በ10 ፌብሩ 2026 · NCT06831552

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 29 Years · ሁሉም ጾታዎች · የተሻሻለው በ26 ዲሴም 2025 · NCT06803875

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።